Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Immunology Letters

• Publication date

  2008-12-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.imlet.2008.09.004PMID 18930766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.

  2008cited by this paper
• MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

  2007cited by this paper
• Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

  2006cited by this paper
• Progression of progressive multifocal leukoencephalopathy despite treatment with β-interferon

  2006cited by this paper
• Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

  2006cited by this paper
• IL-15 Is Elevated in Cerebrospinal Fluid of Patients With Alzheimer’s Disease and Frontotemporal Dementia

  2006cited by this paper
• Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

  2005cited by this paper
• Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosis

  2005cited by this paper
• The nuclear protein HMGB1, a new kind of chemokine?

  2003cited by this paper
• Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients

  2003cited by this paper
• Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells

  2003cited by this paper
• Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm

  2002cited by this paper
• MIG—differential gene expression in mouse brain endothelial cells

  2002cited by this paper
• Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

  2000cited by this paper
• Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease.

  2000cited by this paper
• Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.

  2000cited by this paper
• Inflammation in Alzheimer's disease: a view from the periphery.

  2000cited by this paper
• Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.

  1999cited by this paper
• Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease

  1999cited by this paper
• Novel pathophysiological aspects of macrophage migration inhibitory factor (review).

  1998cited by this paper
• Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

  1998cited by this paper
• Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

  1998cited by this paper
• Advanced multiplexed analysis with the FlowMetrix system.

  1997cited by this paper
• Circulating cytokines in Alzheimer's disease.

  1997cited by this paper
• Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

  1990cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment

  2025cites this paper
• Revealing the heterogeneity of plasma protein and cognitive decline trajectory among Mild Cognitive Impairment patients by clustering of brain atrophy features

  2024cites this paper
• Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes.

  2024cites this paper
• Mediterranean Diet Modulation of Neuroinflammation-Related Genes in Elderly Adults at High Cardiovascular Risk

  2024cites this paper
• Association of postoperative delirium with serum and cerebrospinal fluid proteomic profiles: a prospective cohort study in older hip fracture patients

  2024cites this paper
• Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

  2023cites this paper
• Validating blood tests as a possible routine diagnostic assay of Alzheimer’s disease

  2023cites this paper
• The relevance of serum macrophage migratory inhibitory factor and cognitive dysfunction in patients with cerebral small vascular disease

  2023cites this paper
• Causal effects of circulating cytokine concentrations on risk of Alzheimer’s disease and cognitive function

  2022cites this paper
• Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans

  2021cites this paper
• Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis

  2021cites this paper
• Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia

  2021cites this paper
• The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

  2021cites this paper
• The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective?

  2020cites this paper
• Causal effects of circulating cytokine concentrations on risk of Alzheimers disease: A bidirectional two-sample Mendelian randomization study

  2020cites this paper
• Chemokine profile in Alzheimer's disease: Results from a Mexican population.

  2020cites this paper
• Multivariate Statistical Analysis of Surface Enhanced Raman Spectra of Human Serum for Alzheimer’s Disease Diagnosis

  2019cites this paper
• Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease

  2019cites this paper
• Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease

  2019cites this paper
• A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model.

  2018cites this paper
• Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression?

  2018cites this paper
• Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.

  2017cites this paper
• Development of a human stem cell-based blood-brain barrier model and its use in the study of drug transport in Alzheimer's disease

  2017cites this paper
• Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.

  2017cites this paper
• CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing.

  2016cites this paper
• Systemic inflammation, mild cognitive impairment and Alzheimer’s disease: findings from the PREVENT study

  2016influential citation
• Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis

  2015cites this paper
• CXCR3 ligands in disease and therapy.

  2015cites this paper
• The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

  2015cites this paper
• Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies.

  2014cites this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cites this paper
• Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid.

  2014cites this paper
• Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.

  2014cites this paper
• Effects of Gardeniae Fructus on Cytokines in Mouse Macrophage

  2014cites this paper
• Anti-inflammatory Effect of Coptidis Rhizoma Extract

  2014cites this paper
• Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrPC), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low ai

  2013cites this paper
• Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.

  2013cites this paper
• Improved multimodal biomarkers for Alzheimer's disease and mild cognitive impairment diagnosis: data from ADNI

  2013cites this paper
• The Future Role of Biomarkers in Alzheimer’s Disease Diagnostics

  2013cites this paper
• Anti-Inflammatory Effect of Ligustri Lucidi Fructus Water Extract in RAW 264.7 Cells Induced by LPS

  2013cites this paper
• Effect of Coptidis Rhizoma Extract on Cytokine Production of Mouse Macrophages

  2013cites this paper
• Preliminary Study for a Multicenter Study of Alzheimer's Disease Cerebrospinal Fluid Biomarkers

  2013cites this paper
• High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia

  2012cites this paper
• Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.

  2011cites this paper
• Effect of Scutellariae Radix Extract on the Proinflammatory Mediators in Raw 264.7 Cells Induced by LPS

  2011cites this paper
• Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects

  2011cites this paper
• Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets

  2010cites this paper
• A meta-analysis of cytokines in Alzheimer's disease.

  2010influential citation
• Anti-inflammatory Effects of Fermented Houttuyniae Herba Water Extract on LPS-induced Mouse Macrophage

  2010cites this paper
• Current awareness in geriatric psychiatry

  2009cites this paper
• Peripheral Cytokines and Chemokines in Alzheimer’s Disease

  2009cites this paper